Kopran Ltd.
| BSE: 524280 | Sector: Health care |
| NSE: KOPRAN | ISIN Code: INE082A01010 |
| BSE 16:01 | 06 Aug | 57.10 |
2.70 (4.96%) |
OPEN
54.45 |
HIGH
57.10 |
LOW
54.40 |
| NSE 15:59 | 06 Aug | 57.15 |
2.70 (4.96%) |
OPEN
55.20 |
HIGH
57.15 |
LOW
54.20 |
| OPEN | 54.45 |
| PREVIOUS CLOSE | 54.40 |
| VOLUME | 30556 |
| 52-Week high | 57.10 |
| 52-Week low | 16.15 |
| P/E | 22.05 |
| Mkt Cap.(Rs cr) | 247 |
| Buy Price | 57.10 |
| Buy Qty | 5282.00 |
| Sell Price | 57.00 |
| Sell Qty | 571.00 |
Kopran Ltd. (KOPRAN) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Cipla | 731.70 | 9.15 | 1.27 | 12374.01 |
| Aurobindo Pharma | 909.65 | 48.90 | 5.68 | 12257.89 |
| Dr Reddy's Labs | 4582.30 | -22.40 | -0.49 | 11850.40 |
| Lupin | 936.70 | 8.70 | 0.94 | 11025.66 |
| Sun Pharma.Inds. | 532.20 | 3.20 | 0.60 | 10303.21 |
| Apollo Hospitals | 1694.20 | 18.40 | 1.10 | 8336.66 |
| Alkem Lab | 2863.90 | 21.90 | 0.77 | 6677.08 |
| Cadila Health. | 387.90 | -8.05 | -2.03 | 6492.70 |
| Glenmark Pharma. | 461.10 | 13.35 | 2.98 | 6304.87 |
| Torrent Pharma. | 2977.70 | 117.25 | 4.10 | 6168.44 |
| Divi's Lab. | 2739.85 | 73.60 | 2.76 | 4879.66 |
| Piramal Enterp. | 1463.25 | 30.30 | 2.11 | 4219.19 |
| Alembic Pharma | 1081.55 | 76.35 | 7.60 | 4132.55 |
| Abbott India | 16170.00 | -81.20 | -0.50 | 3678.60 |
| Ipca Labs. | 1969.30 | 9.25 | 0.47 | 3605.66 |
| Glaxosmi. Pharma | 1481.20 | 4.35 | 0.29 | 3224.68 |
| Jubilant Life | 834.00 | 1.95 | 0.23 | 3139.90 |
| Sanofi India | 8166.45 | -116.90 | -1.41 | 3070.60 |
| Laurus Labs | 1033.30 | 4.70 | 0.46 | 2797.34 |
| Nectar Lifesci. | 22.00 | 0.25 | 1.15 | 2784.93 |
Quick Links for Kopran:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
